| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11030702 | Atherosclerosis | 2018 | 9 Pages |
Abstract
Bempedoic acid may provide an oral therapeutic option complementary to ezetimibe in statin intolerant patients who require additional LDL-C lowering.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christie M. Ballantyne, Maciej Banach, G.B. John Mancini, Norman E. Lepor, Jeffrey C. Hanselman, Xin Zhao, Lawrence A. Leiter,